ERBB2 and cancer: Consistent with our earlier finding that EGR4 expression is upregulated in Ras-transformed mammary cells (Figure 1A), EGR4 was highly expressed in cancer cells from the HER2+ subtype, which typically exhibit Ras pathway activation [35].